FDA Inspection
John D. Gabriel, MDJohn D. Gabriel, MD – FDA Inspection, Feb 18, 2016
Record Details
This FDA Inspection record concerns John D. Gabriel, MD, with an inspection on February 18, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- John D. Gabriel, MD
- Inspection Date
- February 18, 2016
- Product Type
- Drugs
View Company Profile
ID · 64d03c1c-c9f2-4f46-b6e9-f4e728be829e
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 963394
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of John D. Gabriel, MD
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 9, 2026 | Not classified | Dallas District Office | |
| March 25, 2022 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 8, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| October 22, 2013 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for John D. Gabriel, MD
- FDA Inspection 1306578 - 2026-03-09
- FDA Inspection 1166625 - 2022-03-25
- FDA Inspection 1044147 - 2018-02-08
- FDA Inspection 852569 - 2013-10-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.